Ben Taub Hospital is a hospital located in Houston, Texas within the Texas Medical Center. Having opened in May 1963, the hospital is owned and operated by the Harris Health System and is staffed by the faculty, residents, and students from Baylor College of Medicine.

There are 586 beds in Ben Taub General Hospital.

During the past decade, Ben Taub General Hospital conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 64 clinical trials were completed, i.e. on average, 90.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 36 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ben Taub General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Baylor College of Medicine" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ben Taub General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Ben Taub General Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Prostate Cancer" (7 trials), "Leukemia" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Ben Taub General Hospital" in a lesser frequency.

Most popular intervention types in "Ben Taub General Hospital" are "Drug" (107 trials), "Other" (69 trials), "Biological" (39 trials), "Procedure" (27 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (24 trials), "Placebo" (15 trials), "Questionnaire Administration" (15 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Ben Taub General Hospital" are 125 trials for "All" genders, 19 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Ben Taub General Hospital". undefined are not yet recruiting, 21 are recruiting, 39 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 76 completed trials in Ben Taub General Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Ben Taub General Hospital, 10 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 22 trials that are defined as “Not Applicable".